Elleder, Daniel et al. published their patent in 2009 |CAS: 64987-16-2

The Article related to nonnucleoside reverse transcriptase inhibitor viral infection treatment, hiv infection treatment nonnucleoside reverse transcriptase inhibitor, Pharmacology: Effects Of Antimicrobials and Parasiticides and other aspects.Related Products of 64987-16-2

On May 14, 2009, Elleder, Daniel; Young, John A. T.; Baiga, Thomas J.; Noel, Joseph P. published a patent.Related Products of 64987-16-2 The title of the patent was Non-nucleoside reverse transcriptase inhibitors. And the patent contained the following:

Disclosed herein are antiviral agents, in particular non-nucleoside reverse transcriptase inhibitors (NNRTIs). Also disclosed are methods of making the NNRTIs, as well as compositions that include such NNRTIs and methods of their use for treating viral infections, in particular retroviral infections, such as HIV infection. The experimental process involved the reaction of Methyl 2-(2-aminothiazol-4-yl)acetate(cas: 64987-16-2).Related Products of 64987-16-2

The Article related to nonnucleoside reverse transcriptase inhibitor viral infection treatment, hiv infection treatment nonnucleoside reverse transcriptase inhibitor, Pharmacology: Effects Of Antimicrobials and Parasiticides and other aspects.Related Products of 64987-16-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica